| abstract |
The present invention discloses methods for detecting, calculating and analyzing circulating tumor cells expressing insulin-like growth factor-1 receptor (IGF-1R). Such methods are useful for screening cancer, adapting and developing treatment regimens, and monitoring treatment response, cancer recurrence, and the like. Test kits are also provided that facilitate the detection, production, and analysis of such circulating tumor cells. |